NPI: 1740468644 · SPRINGDALE, AR 72762 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/04/2008
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/04/2008 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 11,079 | $108K |
| 2019 | 10,989 | $103K |
| 2020 | 10,610 | $99K |
| 2021 | 8,911 | $79K |
| 2022 | 10,736 | $97K |
| 2023 | 3,050 | $39K |
| 2024 | 1,274 | $24K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 18,920 | 1,421 | $192K |
| 83970 | 890 | 754 | $172K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 21,482 | 1,130 | $56K |
| 82728 | 292 | 256 | $29K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 126 | 109 | $26K |
| 82108 | 66 | 58 | $19K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 9,803 | 779 | $16K |
| 83550 | 293 | 256 | $13K | |
| 83540 | 293 | 256 | $11K | |
| A4657 | Syringe, with or without needle, each | 980 | 861 | $6K |
| 85041 | 875 | 754 | $3K | |
| 85048 | 876 | 755 | $2K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 100 | 44 | $1K |
| 82607 | 49 | 42 | $262.54 | |
| 82746 | 65 | 57 | $225.76 | |
| G0008 | Administration of influenza virus vaccine | 17 | 15 | $140.20 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 69 | 56 | $0.00 |
| J1756 | Injection, iron sucrose, 1 mg | 1,453 | 354 | $0.00 |